secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-05-09T23:59:59+00:00
Accession:  0001628280-25-024034
Event type: earnings
Sentiment:  positive
Materiality: 0.78
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Q1 revenue $9.34M (+61% YoY); operating income $1.0M; Q2 guidance 40-50% growth
--------------------------------------------------------------------------------

- Revenue $9.34M, up 61% from $5.79M in Q1 2024; gross margin 79.0% vs 72.6%; GAAP operating income $1.0M.
- Adjusted EBITDA $2.3M vs -$59k in Q1 2024; net loss $5.7M driven by change in fair value of derivative liabilities.
- UltraMist systems sold: 98 (128% increase from 43); consumables revenue +43% to $5.8M.
- Q2 2025 revenue guidance $10.0-10.7M (40-50% YoY); full year 2025 guidance reaffirmed at $48-50M.
- CEO highlights strong pipeline, comfortable inventory levels for larger customer engagements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025024034/0001628280-25-024034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025024034/snwv-20250509.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-024034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer